Cassava Sciences | PTIE - Ebitda

Preço das Ações
1.24
Mudança Diária
0.01 0.81%
Mensal
-22.98%
Anual
-39.51%
Q2 Previsão
1.27




Ebitda Alterar Data
Abbott USD 3.27B 178M 2025-12
Amgen USD 5.14B 775M 2025-12
Biogen USD 649.7M 76.5M 2026-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Eisai JPY 30.1B 6.62B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Geron USD -21.29M 11.82M 2025-12
J&J USD 7.19B 2.32B 2025-12
Merck USD 6.3B 2.09B 2025-12
Novartis USD 5.3B 530M 2026-03
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 5.99B 5.23B 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06